Research Output per year
Fingerprint Fingerprint is based on mining the text of the persons scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.
- 15 Similar Profiles
Neoplasms
Medicine & Life Sciences
Non-Small Cell Lung Carcinoma
Medicine & Life Sciences
Liposomes
Medicine & Life Sciences
Epidermal Growth Factor Receptor
Medicine & Life Sciences
Platinum
Medicine & Life Sciences
Cisplatin
Medicine & Life Sciences
Doxorubicin
Medicine & Life Sciences
Lung Neoplasms
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Publications 1980 2017
18F-Fluorodeoxyglucose/Positron Emission Tomography Predicts Patterns of Failure After Definitive Chemoradiation Therapy for Locally Advanced Non-Small Cell Lung Cancer
Ohri, N., Bodner, W. R., Halmos, B., Cheng, H., Perez-Soler, R., Keller, S. M., Kalnicki, S. & Garg, M. Feb 1 2017 In : International Journal of Radiation Oncology Biology Physics. 97, 2, p. 372-380 9 p.Research output: Contribution to journal › Article
Fluorodeoxyglucose F18
Non-Small Cell Lung Carcinoma
Positron-Emission Tomography
lesions
Neoplasms
Emerging treatment using tubulin inhibitors in advanced non-small cell lung cancer
Hardin, C., Shum, E., Singh, A., Perez-Soler, R. & Cheng, H. May 3 2017 In : Expert Opinion on Pharmacotherapy. 18, 7, p. 701-716 16 p.Research output: Contribution to journal › Review article
Tubulin Modulators
Non-Small Cell Lung Carcinoma
Paclitaxel
Immunotherapy
Biological Markers
HHLA2, a new immune checkpoint member of the B7 family, is widely expressed in human lung cancer and associated with EGFR mutational status
Cheng, H., Janakiram, M., Borczuk, A., Lin, J., Qiu, W., Liu, H., Chinai, J. M., Halmos, B., Perez-Soler, R. & Zang, X. Feb 1 2017 In : Clinical Cancer Research. 23, 3, p. 825-832 8 p.Research output: Contribution to journal › Article
Non-Small Cell Lung Carcinoma
Lung Neoplasms
Neoplasms
Lung
Immunotherapy
Investigational therapies for squamous cell lung cancer: from animal studies to phase II trials
Shum, E., Wang, F., Kim, S., Perez-Soler, R. & Cheng, H. Apr 3 2017 In : Expert Opinion on Investigational Drugs. 26, 4, p. 415-426 12 p.Research output: Contribution to journal › Review article
Squamous Cell Neoplasms
Lung Neoplasms
Immunotherapy
Cytotoxins
Expert Testimony
Pax5 Re-expression in H460 cells treated with the combination of demethylating agent and histone deacetylase inhibitor is associated with the enhancement of P53 binding to Pax5 promoter region
Liang, Y., Zeng, J., Jelicks, L., Ma, S., Liu, J., Mei, J., Perez-Soler, R. & Zou, Y. Feb 1 2017 In : Current Cancer Drug Targets. 17, 2, p. 169-176 8 p.Research output: Contribution to journal › Review article
Azacitidine
Histone Deacetylase Inhibitors
Non-Small Cell Lung Carcinoma
Transcription Factors
DNA